Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains

Journal of Bacteriology

Volumn 192, Issue 4, 2010, Pages 1131-1142

  Daly, Karen M ^a   Upton, Mathew ^b   Sandiford, Stephanie K ^b   Draper, Lorraine A ^a   Wescombe, Philip A ^c   Jack, Ralph W ^c   O'Connor, Paula M ^d   Rossney, Angela ^e   Götz, Friedrich ^f   Hill, Colin ^a,g   Cotter, Paul D ^d,g   Ross, R Paul ^d,g   Tagg, John R ^c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^e ST JAMES S HOSPITAL   (Ireland)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIOCIN; BACTERIOCIN OF STAPHYLOCOCCUS AUREUS; CHLORAMPHENICOL; EPIDERMIN; ERYTHROMYCIN; GALLIDERMIN; LANTIBIOTIC; MERSACIDIN; NISIN; PLASMID DNA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BIOASSAY; COLONY FORMING UNIT; ESCHERICHIA COLI; GRAM POSITIVE BACTERIUM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE SYNTHESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; BACTERIOCINS; COMMUNITY-ACQUIRED INFECTIONS; GENETICS, MICROBIAL; HUMANS; MASS SPECTROMETRY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MUTAGENESIS; PEPTIDES; STAPHYLOCOCCAL INFECTIONS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 75749099326     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.01375-09     Document Type: Article

References (75)

1. Ambulos, N. P., Jr., T. Smith, W. Mulbry, and P. S. Lovett. 1990. CUG as a mutant start codon for cat-86 and xylE in Bacillus subtilis. Gene 94:125-128.
2. Augustin, J., R. Rosenstein, B. Wieland, U. Schneider, N. Schnell, G. Engelke, K. D. Entian, and F. Gotz. 1992. Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur. J. Biochem. 204:1149-1154.
3. Baba, T., T. Bae, O. Schneewind, F. Takeuchi, and K. Hiramatsu. 2008. Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J. Bacteriol. 190:300-310.
4. Baba, T., F. Takeuchi, M. Kuroda, H. Yuzawa, K. Aoki, A. Oguchi, Y. Nagai, N. Iwama, K. Asano, T. Naimi, H. Kuroda, L. Cui, K. Yamamoto, and K. Hiramatsu. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:1819-1827.
5. Bekal-Si Ali, S., Y. Hurtubise, M. C. Lavoie, and G. LaPointe. 2002. Diversity of Streptococcus mutans bacteriocins as confirmed by DNA analysis using specific molecular probes. Gene 283:125-131.
6. Cassat, J. E., P. M. Dunman, F. McAleese, E. Murphy, S. J. Projan, and M. S. Smeltzer. 2005. Comparative genomics of Staphylococcus aureus musculoskeletal isolates. J. Bacteriol. 187:576-592.
7. Chambers, H. F. 2005. Community-associated MRSA - resistance and virulence converge. N. Engl. J. Med. 352:1485-1487.
8. Christianson, S., G. R. Golding, J. Campbell, and M. R. Mulvey. 2007. Comparative genomics of Canadian epidemic lineages of methicillin- resistant Staphylococcus aureus. J. Clin. Microbiol. 45:1904-1911.
9. Cotter, P. D., C. Hill, and R. P. Ross. 2003. A food-grade approach for functional analysis and modification of native plasmids in Lactococcus lactis. Appl. Environ. Microbiol. 69:702-706.
10. Cotter, P. D., C. Hill, and R. P. Ross. 2005. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3:777-788.
11. Cox, C. R., P. S. Coburn, and M. S. Gilmore. 2005. Enterococcal cytolysin: a novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. Curr. Protein Pept. Sci. 6:77-84.
12. Derbise, A., K. G. H. Dyke, and È. N. El Solh. 1994. Isolation and characterization of IS1181, an insertion sequence from Staphylococcus aureus. Plasmid 31:251-264.
13. Deurenberg, R. H., and E. E. Stobberingh. 2009. The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus. Curr. Mol. Med. 9:100-115.
14. Diep, B. A., S. R. Gill, R. F. Chang, T. H. Phan, J. H. Chen, M. G. Davidson, F. Lin, J. Lin, H. A. Carleton, E. F. Mongodin, G. F. Sensabaugh, and F. Perdreau-Remington. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731-739.
15. Diep, B. A., G. F. Sensabaugh, N. S. Somboona, H. A. Carleton, and F. Perdreau-Remington. 2004. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J. Clin. Microbiol. 42:2080-2084.
16. Draper, L. A., K. Grainger, L. H. Deegan, P. D. Cotter, C. Hill, and R. P. Ross. 2009. Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147. Mol. Microbiol. 71:1043-1054.
17. Draper, L. A., R. P. Ross, C. Hill, and P. D. Cotter. 2008. Lantibiotic immunity. Curr. Protein Pept. Sci. 9:39-49.
18. Enright, M. C., N. P. Day, C. E. Davies, S. J. Peacock, and B. G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
19. Feng, Y., C. J. Chen, L. H. Su, S. Hu, J. Yu, and C. H. Chiu. 2008. Evolution and pathogenesis of Staphylococcus aureus: lessons learned from genotyping and comparative genomics. FEMS Microbiol. Rev. 32:23-37.
20. Fey, P. D., B. Said-Salim, M. E. Rupp, S. H. Hinrichs, D. J. Boxrud, C. C. Davis, B. N. Kreiswirth, and P. M. Schlievert. 2003. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:196-203.
21. Frazee, B. W., J. Lynn, E. D. Charlebois, L. Lambert, D. Lowery, and F. Perdreau-Remington. 2005. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann. Emerg. Med. 45:311-320.
22. Geissler, S., F. Gotz, and T. Kupke. 1996. Serine protease EpiP from Staphylococcus epidermidis catalyzes the processing of the epidermin precursor peptide. J. Bacteriol. 178:284-288.
23. Gill, S. R., D. E. Fouts, G. L. Archer, E. F. Mongodin, R. T. Deboy, J. Ravel, I. T. Paulsen, J. F. Kolonay, L. Brinkac, M. Beanan, R. J. Dodson, S. C. Daugherty, R. Madupu, S. V. Angiuoli, A. S. Durkin, D. H. Haft, J. Vamathevan, H. Khouri, T. Utterback, C. Lee, G. Dimitrov, L. Jiang, H. Qin, J. Weidman, K. Tran, K. Kang, I. R. Hance, K. E. Nelson, and C. M. Fraser. 2005. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187:2426-2438.
24. Gillet, Y., B. Issartel, P. Vanhems, J. C. Fournet, G. Lina, M. Bes, F. Vandenesch, Y. Piemont, N. Brousse, D. Floret, and J. Etienne. 2002. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immuno-competent patients. Lancet 359:753-759.
25. Gonzalez, B. E., G. Martinez-Aguilar, K. G. Hulten, W. A. Hammerman, J. Coss-Bu, A. Avalos-Mishaan, E. O. Mason, Jr., and S. L. Kaplan. 2005. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 115:642-648.
26. Grundmann, H., M. Aires-de-Sousa, J. Boyce, and E. Tiemersma. 2006. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368:874-885.
27. Herron-Olson, L., J. R. Fitzgerald, J. M. Musser, and V. Kapur. 2007. Molecular correlates of host specialization in Staphylococcus aureus. PLoS One 2:e1120.
28. Holden, M. T., E. J. Feil, J. A. Lindsay, S. J. Peacock, N. P. Day, M. C. Enright, T. J. Foster, C. E. Moore, L. Hurst, R. Atkin, A. Barron, N. Bason, S. D. Bentley, C. Chillingworth, T. Chillingworth, C. Churcher, L. Clark, C. Corton, A. Cronin, J. Doggett, L. Dowd, T. Feltwell, Z. Hance, B. Harris, H. Hauser, S. Holroyd, K. Jagels, K. D. James, N. Lennard, A. Line, R. Mayes, S. Moule, K. Mungall, D. Ormond, M. A. Quail, E. Rabbinowitsch, K. Rutherford, M. Sanders, S. Sharp, M. Simmonds, K. Stevens, S. Whitehead, B. G. Barrell, B. G. Spratt, and J. Parkhill. 2004. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. U. S. A. 101:9786-9791.
29. Hsu, S. T., E. Breukink, E. Tischenko, M. A. Lutters, B. de Kruijff, R. Kaptein, A. M. Bonvin, and N. A. van Nuland. 2004. The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat. Struct. Mol. Biol. 11:963-967.
30. Huang, Y. H., S. P. Tseng, J. M. Hu, J. C. Tsai, P. R. Hsueh, and L. J. Teng. 2007. Clonal spread of SCCmec type IV methicillin-resistant Staphylococcus aureus between community and hospital. Clin. Microbiol. Infect. 13:717-724.
31. Hyink, O., M. Balakrishnan, and J. R. Tagg. 2005. Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin. FEMS Microbiol. Lett. 252:235-241.
32. Hynes, W. L., V. L. Friend, and J. J. Ferretti. 1994. Duplication of the lantibiotic structural gene in M-type 49 group A streptococcus strains producing streptococcin A-M49. Appl. Environ. Microbiol. 60:4207-4209.
33. Kazakova, S. V., J. C. Hageman, M. Matava, A. Srinivasan, L. Phelan, B. Garfinkel, T. Boo, S. McAllister, J. Anderson, B. Jensen, D. Dodson, D. Lonsway, L. K. McDougal, M. Arduino, V. J. Fraser, G. Killgore, F. C. Tenover, S. Cody, and D. B. Jernigan. 2005. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352:468-475.
34. Kellner, R., G. Jung, T. Horner, H. Zahner, N. Schnell, K. D. Entian, and F. Gotz. 1988. Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur. J. Biochem. 177:53-59.
35. Kreiswirth, B. N., S. Lofdahl, M. J. Betley, M. O'Reilly, P. M. Schlievert, M. S. Bergdoll, and R. P. Novick. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305:709-712.
36. Kupke, T., S. Stevanovic, B. Ottenwalder, J. W. Metzger, G. Jung, and F. Gotz. 1993. Purification and characterization of EpiA, the peptide substrate for post-translational modifications involved in epidermin biosynthesis. FEMS Microbiol. Lett. 112:43-48.
37. Lawton, E. M., R. P. Ross, C. Hill, and P. D. Cotter. 2007. Two-peptide lantibiotics: a medical perspective. Mini Rev. Med. Chem. 7:1236-1247.
38. Leenhouts, K., G. Buist, A. Bolhuis, A. ten Berge, J. Kiel, I. Mierau, M. Dabrowska, G. Venema, and J. Kok. 1996. A general system for generating unlabelled gene replacements in bacterial chromosomes. Mol. Gen. Genet. 253:217-224.
39. Maguin, E., P. Duwat, T. Hege, D. Ehrlich, and A. Gruss. 1992. New thermosensitive plasmid for gram-positive bacteria. J. Bacteriol. 174:5633-5638.
40. Marcille, F., A. Gomez, P. Joubert, M. Ladire, G. Veau, A. Clara, F. Gavini, A. Willems, and M. Fons. 2002. Distribution of genes encoding the trypsin-dependent lantibiotic ruminococcin A among bacteria isolated from human fecal microbiota. Appl. Environ. Microbiol. 68:3424-3431.
41. McAuliffe, O., R. Ross, and C. Hill. 2001. Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol. Rev. 25:285-308.
42. McLaughlin, R. E., J. J. Ferretti, and W. L. Hynes. 1999. Nucleotide sequence of the streptococcin A-FF22 lantibiotic regulon: model for production of the lantibiotic SA-FF22 by strains of Streptococcus pyogenes. FEMS Microbiol. Lett. 175:171-177.
43. Monk, I. R., C. G. Gahan, and C. Hill. 2008. Tools for functional post-genomic analysis of Listeria monocytogenes. Appl. Environ. Microbiol. 74: 3921-3934.
44. Mounier, J., S. Goerges, R. Gelsomino, M. Vancanneyt, K. Vandemeulebroecke, B. Hoste, N. M. Brennan, S. Scherer, J. Swings, G. F. Fitzgerald, and T. M. Cogan. 2006. Sources of the adventitious microflora of a smear-ripened cheese. J. Appl. Microbiol. 101:668-681.
45. Nascimento, J. S., H. Ceotto, S. B. Nascimento, M. Giambiagi-Demarval, K. R. Santos, and M. C. Bastos. 2006. Bacteriocins as alternative agents for control of multiresistant staphylococcal strains. Lett. Appl. Microbiol. 42: 215-221.
46. Navaratna, M. A., H. G. Sahl, and J. R. Tagg. 1998. Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl. Environ. Microbiol. 64:4803-4808.
47. Novick, R. P., and S. I. Morse. 1967. In vivo transmission of drug resistance factors between strains of Staphylococcus aureus. J. Exp. Med. 125:45-59.
48. Okuma, K., K. Iwakawa, J. D. Turnidge, W. B. Grubb, J. M. Bell, F. G. O'Brien, G. W. Coombs, J. W. Pearman, F. C. Tenover, M. Kapi, C. Tiensasitorn, T. Ito, and K. Hiramatsu. 2002. Dissemination of new methicillinresistant Staphylococcus aureus clones in the community. J. Clin. Microbiol. 40:4289-4294.
49. Otto, M., A. Peschel, and F. Gotz. 1998. Producer self-protection against the lantibiotic epidermin by the ABC transporter EpiFEG of Staphylococcus epidermidis Tu3298. FEMS Microbiol. Lett. 166:203-211.
50. Papadelli, M., A. Karsioti, R. Anastasiou, M. Georgalaki, and E. Tsakalidou. 2007. Characterization of the gene cluster involved in the biosynthesis of macedocin, the lantibiotic produced by Streptococcus macedonicus. FEMS Microbiol. Lett. 272:75-82.
51. Peschel, A., and F. Gotz. 1996. Analysis of the Staphylococcus epidermidis genes epiF, -E, and -G involved in epidermin immunity. J. Bacteriol. 178: 531-536.
52. Piper, C., P. D. Cotter, R. P. Ross, and C. Hill. 2009. Discovery of medically significant lantibiotics. Curr. Drug Discov. Technol. 6:1-18.
53. Qi, F., P. Chen, and P. W. Caufield. 2000. Purification and biochemical characterization of mutacin I from the group I strain of Streptococcus mutans, CH43, and genetic analysis of mutacin I biosynthesis genes. Appl. Environ. Microbiol. 66:3221-3229.
54. Qi, F., P. Chen, and P. W. Caufield. 1999. Purification of mutacin III from group III Streptococcus mutans UA787 and genetic analyses of mutacin III biosynthesis genes. Appl. Environ. Microbiol. 65:3880-3887.
55. Robinson, D. A., and M. C. Enright. 2003. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:3926-3934.
56. Robson, C. L., P. A. Wescombe, N. A. Klesse, and J. R. Tagg. 2007. Isolation and partial characterization of the Streptococcus mutans type AII lantibiotic mutacin K8. Microbiology 153:1631-1641.
57. Rossney, A. S., A. C. Shore, P. M. Morgan, M. M. Fitzgibbon, B. O'Connell, and D. C. Coleman. 2007. The emergence and importation of diverse genotypes of methicillin-resistant Staphylococcus aureus (MRSA) harboring the Panton-Valentine leukocidin gene (pvl) reveal that pvl is a poor marker for community-acquired MRSA strains in Ireland. J. Clin. Microbiol. 45:2554-2563.
58. Schenk, S., and R. A. Laddaga. 1992. Improved method for electroporation of Staphylococcus aureus. FEMS Microbiol. Lett. 73:133-138.
59. Schmucker, R., G. Sauermann, U. Eigener, and W. Engel. June 1994. Deodorizing lantibiotic cosmetic agents. U.S. patent 5,318,778.
60. Schnell, N., G. Engelke, J. Augustin, R. Rosenstein, V. Ungermann, F. Gotz, and K. D. Entian. 1992. Analysis of genes involved in the biosynthesis of lantibiotic epidermin. Eur. J. Biochem. 204:57-68.
61. Schnell, N., K. D. Entian, F. Gotz, T. Horner, R. Kellner, and G. Jung. 1989. Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic. FEMS Microbiol. Lett. 49:263-267.
62. Schnell, N., K. D. Entian, U. Schneider, F. Gotz, H. Zahner, R. Kellner, and G. Jung. 1988. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature 333:276-278.
63. Scott, J. C., H.-G. Sahl, A. Carne, and J. R. Tagg. 1992. Lantibiotic-mediated anti-lactobacillus activity of a vaginal Staphylococcus aureus isolate. FEMS Microbiol. Lett. 93:97-102.
64. Sieradzki, K., T. Leski, J. Dick, L. Borio, and A. Tomasz. 2003. Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy. J. Clin. Microbiol. 41:1687-1693.
65. Tagg, J. R., and L. V. Bannister. 1979. "Fingerprinting" β-haemolytic streptococci by their production of and sensitivity to bacteriocin-like inhibitors. J. Med. Microbiol. 12:397-411.
66. Vandenesch, F., T. Naimi, M. C. Enright, G. Lina, G. R. Nimmo, H. Heffernan, N. Liassine, M. Bes, T. Greenland, M. E. Reverdy, and J. Etienne. 2003. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9:978-984.
67. Voyich, J. M., K. R. Braughton, D. E. Sturdevant, A. R. Whitney, B. Said-Salim, S. F. Porcella, R. D. Long, D. W. Dorward, D. J. Gardner, B. N. Kreiswirth, J. M. Musser, and F. R. DeLeo. 2005. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 175:3907-3919.
68. Wang, C. C., W. T. Lo, M. L. Chu, and L. K. Siu. 2004. Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan. Clin. Infect. Dis. 39:481-487.
69. Wescombe, P. A., and J. R. Tagg. 2003. Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes. Appl. Environ. Microbiol. 69:2737-2747.
70. Wescombe, P. A., M. Upton, K. P. Dierksen, N. L. Ragland, S. Sivabalan, R. E. Wirawan, M. A. Inglis, C. J. Moore, G. V. Walker, C. N. Chilcott, H. F. Jenkinson, and J. R. Tagg. 2006. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva. Appl. Environ. Microbiol. 72:1459-1466.
71. Wiedemann, I., T. Bottiger, R. R. Bonelli, A. Wiese, S. O. Hagge, T. Gutsmann, U. Seydel, L. Deegan, C. Hill, P. Ross, and H. G. Sahl. 2006. The mode of action of the lantibiotic lacticin 3147 - a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol. Microbiol. 61:285-296.
72. Willey, J. M., and W. A. van der Donk. 2007. Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 61:477-501.
73. Wirawan, R. E., N. A. Klesse, R. W. Jack, and J. R. Tagg. 2006. Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis. Appl. Environ. Microbiol. 72:1148-1156.
74. Wirawan, R. E., K. M. Swanson, T. Kleffmann, R. W. Jack, and J. R. Tagg. 2007. Uberolysin: a novel cyclic bacteriocin produced by Streptococcus uberis. Microbiology 153:1619-1630.
75. Yeh, C. M., H. K. Chang, H. M. Hsieh, K. Yoda, M. Yamasaki, and Y. C. Tsai. 1997. Improved translational efficiency of subtilisin YaB gene with different initiation codons in Bacillus subtilis and alkalophilic Bacillus YaB. J. Appl. Microbiol. 83:758-763.